GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Sanyou Medical Co 688085.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

13.04

+2.52%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Shanghai Sanyou Medical Co

Its shares trade on Shanghai under the ticker 688085.SS. It has been listed since 9 April 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥542.8m and net income of CN¥63.3m. At that date it held total assets of CN¥2.38bn and shareholders' equity of CN¥2.10bn.

Shanghai Sanyou Medical Co. Ltd. principally engages in the research, development, production, and sale of medical orthopedic implant consumables. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-04-09. The firm's main business is the research, development, manufacturing and sales of medical orthopedic implant consumables. Its main products include spinal implant consumable products and trauma implant consumable products. In addition, the Company also develops and produces supporting surgical tools. The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
9 Apr 2020
Employees
434

Leadership

Pay as last reported

  • Mr. Mingyan LiuChairman of the Board, Chief Scientific Officer, since 2014CN¥1.5m
  • Ms. Nuan NiChief Financial Officer
  • Mr. Nong XuGeneral Manager, Director, since 2019CN¥1.3m
  • Mr. Xianglong FanDeputy General Manager, Secretary of the Board, Director, since 2019CN¥900,000
  • Mr. Xubo HuDirector
  • Mr. Chongjun RenDirectorCN¥695,700
  • Ms. Xiaoyi ZhengDirectorCN¥817,500
  • Mr. Fang ChengIndependent Director
  • Mr. Zhongmin JinIndependent DirectorCN¥120,000
  • Ms. Mochou LiIndependent Director
  • Mr. Songshan LiuIndependent DirectorCN¥120,000
  • Rui SongIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Shanghai with 434 employees
  • Engages in research, development, production, and sale of medical orthopedic implant consumables
  • Main products include spinal and trauma implant consumable products

Weaknesses

  • No specific weaknesses mentioned in the provided information
  • No details on financial performance or market share provided
  • No information on competitive advantages or unique technologies

Opportunities

  • Expanding domestic and overseas market distribution
  • Growth potential in medical orthopedic implant consumables market
  • Development and production of supporting surgical tools

Threats

  • No specific threats mentioned in the provided information
  • No details on regulatory challenges or market competition
  • No information on economic or industry risks

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.